Conway Capital Management Inc. Makes New $2.25 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Conway Capital Management Inc. acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 4,569 shares of the medical equipment provider’s stock, valued at approximately $2,245,000. Intuitive Surgical comprises approximately 1.1% of Conway Capital Management Inc.’s portfolio, making the stock its 19th biggest holding.

Several other large investors have also modified their holdings of the stock. Massachusetts Financial Services Co. MA purchased a new position in Intuitive Surgical during the third quarter worth approximately $558,807,000. International Assets Investment Management LLC increased its holdings in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after buying an additional 1,088,415 shares during the last quarter. FMR LLC raised its position in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares during the period. Strategic Financial Concepts LLC boosted its holdings in Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after acquiring an additional 265,461 shares during the last quarter. Finally, State Street Corp grew its position in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the sale, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 50,485 shares of company stock valued at $26,128,102. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners lifted their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Citigroup boosted their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $541.33.

Intuitive Surgical Trading Down 2.1 %

Shares of NASDAQ:ISRG opened at $538.86 on Tuesday. The firm has a market cap of $191.93 billion, a PE ratio of 86.63, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. The company has a fifty day simple moving average of $517.16 and a 200 day simple moving average of $475.65. Intuitive Surgical, Inc. has a 12-month low of $309.80 and a 12-month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.